Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration
Main Authors: | Michaeline Hebron, Charbel E-H Moussa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=11;spage=1767;epage=1769;aulast=Hebron |
Similar Items
-
Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
by: Alan J. Fowler, et al.
Published: (2019-03-01) -
Neutrophils in Cancer: Two Sides of the Same Coin
by: Eileen Uribe-Querol, et al.
Published: (2015-01-01) -
Feedforward inhibition and synaptic scaling--two sides of the same coin?
by: Christian Keck, et al.
Published: (2012-01-01) -
On Naevi and Melanomas: Two Sides of the Same Coin?
by: Katie J. Lee, et al.
Published: (2021-02-01) -
Multimorbidity or Polypharmacy: Two Sides of the Same Coin?
by: Carol Sinnott, et al.
Published: (2015-01-01)